CliffBio
small molecule

SEROQUEL XR

QUETIAPINE FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyCHEPLAPHARM ARZNEIMITTEL GMBH

Drug detail

Brand nameSEROQUEL XR
Active ingredientQUETIAPINE FUMARATE
StrengthEQ 150MG BASE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2008
Marketing statusRX

More from CHEPLAPHARM ARZNEIMITTEL GMBH

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.